Schwabe Stefan K.F. 4
4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Feb 25, 2020
Insider Transaction Report
Form 4
Schwabe Stefan K.F.
Executive Vice President R&D
Transactions
- Award
Employee Stock Option (Right to Buy)
2020-02-21+50,000→ 50,000 totalExercise: $23.99Exp: 2030-02-21→ Common Stock (50,000 underlying)
Holdings
- 2,772
Common Stock
Footnotes (2)
- [F1]Includes an aggregate of 458 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4.
- [F2]The option vests in four equal annual installments beginning on February 21, 2021.